Contact this trialFirst, we need to learn more about you.
Virus Therapy
TAVO412 for Cancer
Recruiting1 awardPhase 1
New York, New York
This trial will test the safety and effectiveness of a new drug, TAVO412, for advanced/metastatic solid tumors in two parts. Part 1 will determine the best dose and Part 2 will assess safety, effectiveness, and other measures for gastric cancer and NSCLC.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.